Aperio Group, LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 195 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$311,000
-25.2%
12,575
+25.4%
0.00%0.0%
Q3 2020$416,000
+61.2%
10,024
+85.9%
0.00%0.0%
Q2 2020$258,000
-18.4%
5,393
+7.4%
0.00%0.0%
Q1 2020$316,000
-55.2%
5,023
-11.8%
0.00%
-66.7%
Q4 2019$705,000
+111.1%
5,693
+13.1%
0.00%
+200.0%
Q3 2019$334,000
-13.5%
5,032
+3.8%
0.00%
-50.0%
Q2 2019$386,000
-28.4%
4,846
+0.5%
0.00%0.0%
Q1 2019$539,000
+20.0%
4,820
+8.3%
0.00%0.0%
Q4 2018$449,000
-16.7%
4,451
+4.3%
0.00%0.0%
Q3 2018$539,000
+49.3%
4,269
-0.7%
0.00%0.0%
Q2 2018$361,000
+14.2%
4,297
-16.3%
0.00%0.0%
Q1 2018$316,000
+49.1%
5,132
+193.1%
0.00%
+100.0%
Q2 2017$212,000
-41.3%
1,751
-20.2%
0.00%
-66.7%
Q3 2016$361,000
+30.8%
2,194
+13.6%
0.00%
+50.0%
Q2 2016$276,0000.0%1,931
-10.3%
0.00%0.0%
Q1 2016$276,000
+12.7%
2,152
+31.2%
0.00%0.0%
Q4 2015$245,000
+14.5%
1,640
+27.1%
0.00%0.0%
Q3 2015$214,000
-18.0%
1,290
+19.4%
0.00%
-33.3%
Q2 2015$261,0001,0800.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders